KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies

Qing Wen, Philip D. Dunne, Paul G. O’Reilly, Gerald Li, Tony Bjourson, Darragh G. McArt, Peter W. Hamilton, Shu-Dong Zhang*

Research output: Contribution to journalArticle

5 Citations (Scopus)
LanguageEnglish
Pages3206-3225
Number of pages19
JournalOncotarget
Volume8
Issue number2
Early online date10 Dec 2016
DOIs
Publication statusPublished - 10 Jan 2017

Keywords

  • connectivity mapping
  • differentially expressed genes
  • colorectal cancer
  • KRAS mutation
  • FDA approved drugs
  • angiotensin II receptor blockers (ARBs)

Cite this

Wen, Qing ; Dunne, Philip D. ; O’Reilly, Paul G. ; Li, Gerald ; Bjourson, Tony ; McArt, Darragh G. ; Hamilton, Peter W. ; Zhang*, Shu-Dong. / KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. In: Oncotarget. 2017 ; Vol. 8, No. 2. pp. 3206-3225.
@article{76cc5a305c114fa6bae0c52b3faa76ac,
title = "KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies",
keywords = "connectivity mapping, differentially expressed genes, colorectal cancer, KRAS mutation, FDA approved drugs, angiotensin II receptor blockers (ARBs)",
author = "Qing Wen and Dunne, {Philip D.} and O’Reilly, {Paul G.} and Gerald Li and Tony Bjourson and McArt, {Darragh G.} and Hamilton, {Peter W.} and Shu-Dong Zhang*",
year = "2017",
month = "1",
day = "10",
doi = "10.18632/oncotarget.13884",
language = "English",
volume = "8",
pages = "3206--3225",
journal = "Oncotarget",
issn = "1949-2553",
number = "2",

}

KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies. / Wen, Qing; Dunne, Philip D.; O’Reilly, Paul G.; Li, Gerald; Bjourson, Tony; McArt, Darragh G.; Hamilton, Peter W.; Zhang*, Shu-Dong.

In: Oncotarget, Vol. 8, No. 2, 10.01.2017, p. 3206-3225.

Research output: Contribution to journalArticle

TY - JOUR

T1 - KRAS mutant colorectal cancer gene signatures identified angiotensin II receptor blockers as potential therapies

AU - Wen, Qing

AU - Dunne, Philip D.

AU - O’Reilly, Paul G.

AU - Li, Gerald

AU - Bjourson, Tony

AU - McArt, Darragh G.

AU - Hamilton, Peter W.

AU - Zhang, Shu-Dong

PY - 2017/1/10

Y1 - 2017/1/10

KW - connectivity mapping

KW - differentially expressed genes

KW - colorectal cancer

KW - KRAS mutation

KW - FDA approved drugs

KW - angiotensin II receptor blockers (ARBs)

U2 - 10.18632/oncotarget.13884

DO - 10.18632/oncotarget.13884

M3 - Article

VL - 8

SP - 3206

EP - 3225

JO - Oncotarget

T2 - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 2

ER -